Medgenome Unlisted Shares

Medgenome Share Price

DMAT

PUBLIC LIMITED

Price Chart

1W

1M

1Y

MAX

High

₹2,328

Low

₹2,328

Return

-

Buy Sell Medgenome Unlisted Shares

As of September 23, 2026, Medgenome Labs, Unlisted Shares are trading at ₹2,328.00 per share and face value is ₹10.00/share, with a 52-week high of ₹2,328.00 and 52-week low of ₹2,328.00. The minimun lot size is None shares, and the shares are traded on .

ISIN

INE00K701014

Face Value

10

Total Shares

24,88,893

Market Cap

579.41 Cr

Sector

Health Care

Sub-sector

Hospitals & Diagnostics Centres

About Medgenome

Company Overview:

MedGenomeis a global leader in Genetic Testing services, Genomics Research, and drug discovery solutions. It operates a multi-pronged business model that capitalizes on the growing demand for personalized medicine and genetic insights.
MedGenome has been committed to delivering world-class genomic solutions with greater precision and accuracy to empower every human being for better management of their health since 2013. MedGenome utilizes advanced technologies like Next-Generation Sequencing (NGS) for in-depth genetic analysis, aiding in complex diagnosis and personalized treatment plans.
MedGenome is the only CAP-accredited Genetic testing lab in India that offers 1300+ genetic tests backed by the best and the latest testing technologies available across the world. MedGenome is dedicated to bringing the best precision testing solutions for quicker and smarter diagnosis of complex diseases. It operates the largest College of American Pathologists (CAP) accredited Next-Generation Sequencing (NGS) lab in South East Asia housing cutting-edge genome sequencing platforms such as Illumina's NovaSeq, HiSeq X, MiSeq, etc.
MedGenome actively engages in research and development services, partnering with pharmaceutical companies and research institutions. This segment offers various services like collaborating on projects related to drug discovery, pharmacogenomics, and biomarker development; storing and managing biological samples for future research endeavors; and providing expertise and infrastructure to conduct genomics and personalized medicine trials.
MedGenome recognized the value of strategic partnerships and collaboration with various entities including hospitals and clinics which expands their market reach and allows them to offer comprehensive care solutions to patients; pharmaceutical and research institutions which facilitate joint research projects, drug development initiatives, and clinical trials, accelerating advanced in the filed; technology companies which allow MedGenome to develop innovative solutions for data analysis, genetic testing, and personalized medicine applications.
MedGenome Labs Limited was incorporated on 8 April 2013, with its registered office at No. 258/A,3rd Floor Narayana Nethralaya, Narayana Health City, Hosur Road, Bommasandra Bangalore Bangalore KA 560099 IN.